Hikma Pharmaceutical | HIK - Debt


Hikma Pharmaceutical reported $1.6B in Debt for its fiscal semester ending in December of 2025.





Debt Change Date
Almirall EUR 342.86M 61.94M Dec/2025
argenx SE USD 47.16M 4.01M Dec/2025
AstraZeneca USD 32.24B 1.68B Jun/2026
Autolus Therapeutics Ltd USD 253.44M 8.84M Mar/2025
Bayer EUR 36.45B 2.93B Dec/2025
Fresenius EUR 11.9B 28M Mar/2026
Genmab DKK 5.35B 5.2B Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
GRIFOLS EUR 8.52B 1.15B Jun/2026
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 12.04B 86M Mar/2026
Orion EUR 330.3M 24.9M Mar/2026
Recordati EUR 2.31B 57.06M Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
UCB EUR 3.03B 12M Dec/2024